scholarly journals Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial

2017 ◽  
Vol 92 (4) ◽  
pp. 359-366 ◽  
Author(s):  
Agnieszka Pluta ◽  
Tadeusz Robak ◽  
Agata Wrzesien-Kus ◽  
Bozena Katarzyna Budziszewska ◽  
Kazimierz Sulek ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Phase Ii ◽  
Myeloid Leukemia ◽  
Phase Ii Trial ◽  
Induction Treatment ◽  
Adult Leukemia ◽  
Leukemia Group ◽  
Acute Myeloid

Phase II trial of CPX-351 in patients with acute myeloid leukemia at high risk for induction mortality

Leukemia ◽  
2020 ◽  
Vol 34 (11) ◽  
pp. 2914-2924
Author(s):  
Ghayas C. Issa ◽  
Hagop M. Kantarjian ◽  
Lianchun Xiao ◽  
Jing Ning ◽  
Yesid Alvarado ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
High Risk ◽  
Phase Ii ◽  
Myeloid Leukemia ◽  
Phase Ii Trial ◽  
Acute Myeloid

scholarly journals A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients

Leukemia ◽  
1999 ◽  
Vol 13 (10) ◽  
pp. 1491-1496 ◽  
Author(s):  
R Bouabdallah ◽  
F Lefrère ◽  
C Rose ◽  
P Chaïbi ◽  
J-L Harousseau ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Elderly Patients ◽  
Phase Ii ◽  
Myeloid Leukemia ◽  
Phase Ii Trial ◽  
Consolidation Therapy ◽  
Poor Risk ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document